Stock analysts at Maxim Group began coverage on shares of Yield10 Bioscience (NASDAQ:YTEN) in a research note issued to investors on Thursday, The Fly reports. The firm set a “buy” rating on the specialty chemicals company’s stock.
Shares of NASDAQ YTEN opened at $1.40 on Thursday. The firm has a market capitalization of $13.49 million, a PE ratio of -0.43 and a beta of 3.21. Yield10 Bioscience has a fifty-two week low of $1.35 and a fifty-two week high of $8.67. The company has a debt-to-equity ratio of 0.08, a current ratio of 8.45 and a quick ratio of 8.45.
Yield10 Bioscience (NASDAQ:YTEN) last announced its quarterly earnings results on Thursday, May 10th. The specialty chemicals company reported ($0.24) earnings per share for the quarter. The company had revenue of $0.06 million during the quarter. Yield10 Bioscience had a negative net margin of 1,410.88% and a negative return on equity of 131.88%. equities research analysts predict that Yield10 Bioscience will post -2.71 earnings per share for the current year.
Yield10 Bioscience Company Profile
Yield10 Bioscience, Inc, an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company, through its Smart Carbon Grid for Crops and T3 platforms, is involved in improving fundamental crop yield through enhanced photosynthetic carbon capture, as well as increased carbon utilization efficiency to increase seed yield.
Receive News & Ratings for Yield10 Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yield10 Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.